{"altmetric_id":1940966,"counts":{"readers":{"mendeley":3,"citeulike":0,"connotea":0},"total":{"posts_count":1},"twitter":{"unique_users_count":1,"unique_users":["ExpertOpinion"],"posts_count":1}},"citation":{"abstract":"Androgen deprivation therapy is the mainstay treatment for patients with prostate cancer who are not candidates for definitive treatment, are diagnosed with advanced disease on initial presentation or progress after primary treatment. Patients who stop responding to androgen deprivation therapy develop castration resistant prostate cancer (CRPC). Emerging drugs undergoing clinical evaluation and drugs that have recently received FDA approval for the treatment of CRPC are reviewed.","abstract_source":"pubmed","altmetric_jid":"4f6fa6173cf058f6100073c4","authors":["Paul H Chung","Bishoy A Gayed","Gregory R Thoreson","Ganesh V Raj"],"doi":"10.1517\/14728214.2013.864635","endpage":"550","first_seen_on":"2013-11-28T11:14:25+00:00","issns":["1472-8214","1744-7623"],"issue":"4","journal":"Expert Opinion on Emerging Drugs","last_mentioned_on":1385637259,"links":["http:\/\/informahealthcare.com\/doi\/abs\/10.1517\/14728214.2013.864635"],"pmid":"24274615","pubdate":"2013-12-01T00:00:00+00:00","publisher_subjects":[{"name":"Pharmacology And Pharmaceutical Sciences","scheme":"era"}],"scopus_subjects":["Health Sciences","Medicine","Life Sciences","Pharmacology, Toxicology and Pharmaceutics"],"startpage":"533","subjects":["drugtherapy"],"title":"Emerging drugs for prostate cancer.","type":"article","volume":"18","mendeley_url":"http:\/\/www.mendeley.com\/research\/emerging-drugs-prostate-cancer-5"},"altmetric_score":{"score":0.25,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":0.25},"context_for_score":{"all":{"total_number_of_other_articles":5036908,"mean":5.9657355758162,"rank":4201156,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":5036908,"percentile":1},"similar_age_3m":{"total_number_of_other_articles":130381,"mean":7.2574180855962,"rank":105519,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":130381,"percentile":1},"this_journal":{"total_number_of_other_articles":178,"mean":1.5437853107345,"rank":144,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":178,"percentile":1},"similar_age_this_journal_3m":{"total_number_of_other_articles":9,"mean":1.1875,"rank":7,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":9,"percentile":1}}},"demographics":{"poster_types":{"member_of_the_public":1},"users":{"twitter":{"cohorts":{"Members of the public":1}},"mendeley":{"by_status":{"Researcher":1,"Student  > Ph. D. Student":1,"Student  > Bachelor":1},"by_discipline":{"Medicine and Dentistry":1,"Chemistry":1,"Agricultural and Biological Sciences":1}}},"geo":{"twitter":{"GB":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/ExpertOpinion\/status\/406018211751022592","license":"public","citation_ids":[1940966],"posted_on":"2013-11-28T11:14:19+00:00","author":{"name":"Expert Opinion","url":"http:\/\/explore.tandfonline.com\/content\/med\/medicine-hub\/expert-collection","image":"https:\/\/pbs.twimg.com\/profile_images\/489823721943625728\/-Bu_ucgW_normal.png","description":"11 peer-reviewed journals, analyzing the pharma research pipeline, phase by phase","id_on_source":"ExpertOpinion","tweeter_id":"29176129","geo":{"lt":51.50853,"ln":-0.12574,"country":"GB"},"followers":1831},"tweet_id":"406018211751022592"}]}}